Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headline Title

Hematologic Diseases
Clinical Trials
Leukemia and Lymphoma
Protocol Number Long Title Study Status PI Website Section
08C0051
Pilot
A Pilot Trial of WT1 Peptide-Loaded Allogeneic Dendritic Cell Vaccine and Donor Lymphocyte Infusion for WT1-Expressing Hematologic Malignancies Open to Accrual Alan Wayne Link Hematologic/Blood Cancers
06C0233
Phase 1
A Phase I Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias Open to Accrual Brigitte Widemann Link Pharmacology & Experimental Therapeutics, Sarcoma, Hematologic Diseases
08C0123
Phase 1
A Phase 1, Multi-Center, Dose Escalation Study of CAT-8015 in Children, Adolescents, and Young Adults with Refractory CD22+ Acute Lymphoblastic Leukemia (all) or Non-Hodgkin's Lymphoma (NHL) Open to Accrual Alan Wayne Link Pharmacology & Experimental Therapeutics, Hematologic Diseases
10C0119
Phase 1
A Phase 1 Study of Vorinostat and Bortezomib in Children with Refractory or Recurrent Solid Tumors, Including CNS Tumors and Lymphomas Open to Accrual Brigitte Widemann   Pharmacology & Experimental Therapeutics, Hematologic Diseases, Sarcoma, NeuroOncology
04C0173
Phase 2
Phase II Study of UCN-01 in Relapsed or Refractory Systemic Anaplastic Large Cell and Mature T-Cell Lymphomas  Open to Accrual Wyndham Wilson Link Hematologic Diseases
01C0030
Other
Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated Lymphomas  Open to Accrual Wyndham Wilson Link Hematologic Diseases
04C0102
Other
Hematologic Malignancy Biology Study Open to Accrual Alan Wayne   Hematologic Diseases
10C0019
Other
Development and validation of a symptom scale for children with chronic graft-versus-host disease Open to Accrual Lori Wiener   Hematologic Diseases, Psychosomatic
11C0073 A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias Open to Accrual Kristin Baird Link Sarcoma

 

Coming Trials:

  1. A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias. 
  2. R049 COG Trial

Currently Closed to Accrual:

  1. 01-C-0125   Pilot Study of Non-myeloablative,
    HLA-matched Allogeneic Stem Cell
Dashed Line

return to the top

This Page Last Reviewed on February 26, 2013

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov